Covered recipient · General Payments record
VICKI G NOWAK
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2024
$2,121.73
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.94 | 14 |
| Travel and Lodging | $339.37 | 1 |
| Gift | $3.85 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acclarent, Inc | $470.26 | 6 |
| GENZYME CORPORATION | $168.40 | 6 |
| Medtronic, Inc. | $63.20 | 1 |
| GlaxoSmithKline, LLC. | $35.49 | 2 |
| Regeneron Healthcare Solutions, Inc. | $22.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acclarent, Inc | $9.86 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077574158 | CMS |
| Acclarent, Inc | $39.78 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077574150 | CMS |
| Acclarent, Inc | $43.00 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077574152 | CMS |
| Acclarent, Inc | $3.85 | 02/17/2024 | Gift | Undisputed | 01/23/2026 | 1077574154 | CMS |
| Acclarent, Inc | $34.40 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077574156 | CMS |
| Acclarent, Inc | $339.37 | 02/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1077574160 | CMS |
| GENZYME CORPORATION | $27.66 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986076 | CMS |
| GENZYME CORPORATION | $37.68 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986078 | CMS |
| GENZYME CORPORATION | $22.59 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986086 | CMS |
| GENZYME CORPORATION | $27.41 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986138 | CMS |
| GENZYME CORPORATION | $21.26 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986152 | CMS |
| GENZYME CORPORATION | $31.80 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986158 | CMS |
| GlaxoSmithKline, LLC. | $15.85 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116399584 | CMS |
| GlaxoSmithKline, LLC. | $19.64 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115851452 | CMS |
| Medtronic, Inc. | $63.20 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119434531 | CMS |
| Regeneron Healthcare Solutions, Inc. | $22.81 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114126142 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.